Dakar — A study published this month in the Lancet medical journal found a new meningitis vaccine being used in Chad reduced the incidence of the disease by 94 percent. According to the World Health Organization, meningitis affects nearly half a billion people living in sub-Saharan Africa each year and, even with proper treatment, is often deadly.
Researchers say the first meningitis vaccine developed specifically for Africa has "dramatically reduced" the number of cases of the disease in Chad, as well as prevented its spread.
...
AllAfrica Subscription Content
You must be an allAfrica.com subscriber for full access to certain content.
You have selected an article from the AllAfrica archive, which requires a subscription. You can subscribe by visiting our subscription page. Or for more information about becoming a subscriber, you can read our subscription and contribution overview.
For information about our premium subscription services:
You can also freely access - without a subscription - hundreds of today's top Africa stories and thousands of recent news articles from our home page »
Already a subscriber? Sign in for full access to article